Boardroom Disputes

How do capital raises and dilution disputes arise, and how can they be resolved?

USD 49 single Risk Briefing|Delivered within 4 hours|Reference material, not advice
Configure your report

What this risk is, and why it matters

Capital raises and the dilution they create are a frequent trigger for board and shareholder disputes, especially where existing holders believe an issue was underpriced, structured to benefit insiders, or used to shift control. They matter because directors authorising an issue must act for proper purposes and even-handedly, and a contested raise can draw oppression claims, injunctions and regulatory scrutiny at the worst possible moment. For a senior executive, a funding round handled without process can become a governance crisis.

Legal and regulatory framework

Share issues engage pre-emption rights, proper-purpose duties on directors, shareholder-approval thresholds and, for listed companies, listing rules on placings, discounts and related-party participation. Courts scrutinise issues that entrench control or dilute a minority unfairly. Governance codes reinforce even-handed treatment. The report sets out the pre-emption, approval and proper-purpose framework applicable to your chosen jurisdiction and industry.

Typical scenarios and impact

Scenarios include a discounted placing to insiders, a rights issue a minority cannot follow, or a raise that dilutes a rival faction before a vote. Consequences range from injunctions and unwound issues to oppression claims and regulatory criticism, alongside reputational harm with investors. Costs combine legal expense with the impaired ability to raise future capital. The report offers hedged ranges rather than naming specific figures as fact.

Mitigation framework and when to engage an expert

A defensible raise respects pre-emption or properly disapplies it, follows required approvals, prices on independent advice, and documents the genuine funding rationale rather than any control effect. Where insiders participate, independent oversight is essential. Engage corporate counsel on approvals and proper purpose, independent directors to oversee insider participation, and valuation experts on pricing, so the raise withstands challenge as a financing rather than a manoeuvre.

Read the report. Talk to an expert.

This research is a starting point, not a verdict.

A Risk Briefing in the Boardroom Disputes Domain tells you what the risk looks like, what the law says, and what indicators to watch. It does not replace a senior adviser who knows your jurisdiction, your industry, and your specific exposure. Senior advisors who have published on this exact question for your country appear at the bottom of this page once you have configured for a country. Download a Report for free; contact details live inside each PDF.

Configure for your country and industry

Pick a jurisdiction and an industry. Receive the report within 4 hours.

Country, optional state or region, and optional industry. Single Risk Briefing USD 49. Or buy the entire Domain Bundle (45 Risk Briefings) for USD 1,544 Save USD 661 (30%).

For Expert-Partners

Publish on this exact question

Buyers researching this risk in their country see your Report on this page. A Single Seat is USD 495 a year, up to five firms per page, and a Pro Seat is USD 1,485 for the larger card at the top. All 45 Boardroom questions in one country cost USD 15,592.50/yr (save usd 6,682.50 (30%)). Registration is free and shows which of them are open before you choose.

Reference material for informed readers, not professional advice. Reports are produced against current, verifiable sources; material claims are referenced. Always consult a qualified adviser before acting on the contents of a report. Browse all Intelligence Reports.